Stocks › CVS

CVS HEALTH Corp

CVS·NYSE·United States United States·USD
$80.84
+0.80 (+1.00%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CVS
CVS HEALTH Corp · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CVSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of CVS by members of U.S. Congress · 384 on record · 22 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Stock Purchase
$1,001 - $15,000
Nov 5, 2026 Oct 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Stock Sale
$1,001 - $15,000
Nov 5, 2026 Oct 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Common Stock Sale
$15,001 - $50,000
Oct 8, 2026 Sep 4, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Common Stock Sale
$1,001 - $15,000
Sep 5, 2026 Aug 24, 2026 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL CVSCVS HEALTH Corp · Stock Sale
$1,001 - $15,000
Aug 5, 2026 Aug 26, 2024 Filing ↗
Alan ArmstrongAlan ArmstrongSenate · R · OK CVSCVS HEALTH Corp · Stock Purchase
$1,001 - $15,000
Jul 21, 2026 Mar 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Common Stock Purchase
$1,001 - $15,000
Jul 7, 2026 Jun 2, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Stock Purchase
$1,001 - $15,000
Jun 10, 2026 May 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Common Stock Purchase
$1,001 - $15,000
Jun 10, 2026 May 1, 2026 Filing ↗
Dwight EvansDwight EvansHouse · D · PA CVSCVS HEALTH Corp · Stock Sale
$1,001 - $15,000
May 15, 2026 Nov 21, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Common Stock Purchase
$1,001 - $15,000
May 11, 2026 Apr 13, 2026 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX CVSCVS HEALTH Corp · Stock Purchase
$15,001 - $50,000
Mar 10, 2026 Feb 20, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Stock Sale
$1,001 - $15,000
Mar 9, 2026 Feb 24, 2026 Filing ↗
John BoozmanJohn BoozmanSenate · R · AR CVSCVS HEALTH Corp · Stock Purchase
$1,001 - $15,000
Feb 15, 2026 Jan 29, 2026 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX CVSCVS HEALTH Corp · Stock Sale
$15,001 - $50,000
Feb 11, 2026 Jan 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CVSCVS HEALTH Corp · Common Stock Sale
$1,001 - $15,000
Feb 6, 2026 Jan 29, 2026 Filing ↗
Julia LetlowJulia LetlowHouse · R · LA CVSCVS HEALTH Corp · Cash Purchase
$1,001 - $15,000
Jan 13, 2026 Oct 25, 2024 Filing ↗
Julia LetlowJulia LetlowHouse · R · LA CVSCVS HEALTH Corp · Cash Sale
$1,001 - $15,000
Jan 13, 2026 Dec 11, 2024 Filing ↗
Dwight EvansDwight EvansHouse · D · PA CVSCVS HEALTH Corp · Stock Sale
$1,001 - $15,000
Dec 19, 2025 Nov 21, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI CVSCVS HEALTH Corp · Stock Purchase
$1,001 - $15,000
Nov 21, 2025 Oct 30, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI CVSCVS HEALTH Corp · Stock Sale
$1,001 - $15,000
Nov 21, 2025 Oct 30, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI CVSCVS HEALTH Corp · Stock Sale
$1,001 - $15,000
Nov 21, 2025 Oct 31, 2025 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX CVSCVS HEALTH Corp · Stock Sale
$15,001 - $50,000
Nov 10, 2025 Oct 27, 2025 Filing ↗
Val T. HoyleVal T. HoyleHouse · D · OR CVSCVS HEALTH Corp · Stock Sale
$1,001 - $15,000
Oct 10, 2025 Sep 23, 2025 Filing ↗
Val T. HoyleVal T. HoyleHouse · D · OR CVSCVS HEALTH Corp · Stock Purchase
$1,001 - $15,000
Sep 12, 2025 Oct 29, 2024 Filing ↗

Whale Activity

Position changes in CVS reported for 2026-09-30 by 2189 institutional filers
Increased: 795New: 137Held: 250Decreased: 726Closed: 189No prior filing: 92
  • Increased795
  • New137
  • Held250
  • Decreased726
  • Closed189
  • No prior filing92
FilerSharesValueChange
BlackRock, Inc.120.4M$10.32Bdecreased
VANGUARD CAPITAL MANAGEMENT LLC83.7M$7.17Bincreased
Capital World Investors74.0M$6.35Bdecreased
STATE STREET CORP60.1M$5.15Bdecreased
DODGE & COX46.0M$3.95Bdecreased
WELLINGTON MANAGEMENT GROUP LLP36.7M$3.14Bincreased
GEODE CAPITAL MANAGEMENT, LLC30.9M$2.64Bincreased
VANGUARD PORTFOLIO MANAGEMENT LLC27.1M$2.32Bincreased
FMR LLC24.9M$2.13Bdecreased
BANK OF AMERICA CORP /DE/23.6M$2.02Bincreased
JPMORGAN CHASE & CO22.1M$1.93Bincreased
Capital Research Global Investors21.9M$1.87Bdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by CVS insiders, by quarter · Form 4
-5.0M-2.5M02.5M5.0M2025 Q1: 22.5K2025 Q12025 Q2: -3.7M2025 Q22025 Q3: -7,5002025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: -3.4M2026 Q22026 Q3: 02026 Q32026 Q4: 23.9K2026 Q4

Recent Insider Transactions

1,893 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Shah Prem SEVP and Group President Purchase +23.9K $83.89 $2.0M Nov 6, 2026 Form 4 ↗
Clark James DavidSVP, Cont & Chief Acct Officer Tax withholding −454 $90.98 $41K Jun 26, 2026 Form 4 ↗
Newman BrianEVP, Chief Financial Officer Tax withholding −2,478 $90.98 $225K May 31, 2026 Form 4 ↗
Compton-Phillips AmyEVP, Chief Medical Officer Tax withholding −7,618 $90.98 $693K May 31, 2026 Form 4 ↗
AGUIRRE FERNANDODirector Disposition to issuer −1,563 $93.50 $146K May 21, 2026 Form 4 ↗
ROBBINS LARRYDirector Sale −370.5K $93.45 $34.6M May 21, 2026 Form 4 ↗
AGUIRRE FERNANDODirector Disposition to issuer −30.4K $93.78 $2.9M May 20, 2026 Form 4 ↗
ROBBINS LARRYDirector Sale −800 $96.28 $77K May 20, 2026 Form 4 ↗
ROBBINS LARRYDirector Sale −66.9K $95.67 $6.4M May 20, 2026 Form 4 ↗
ROBBINS LARRYDirector Sale −152.7K $94.81 $14.5M May 20, 2026 Form 4 ↗
ROBBINS LARRYDirector Sale −797.6K $93.48 $74.6M May 20, 2026 Form 4 ↗
ROBBINS LARRYDirector Sale −151 $95.18 $14K May 19, 2026 Form 4 ↗
ROBBINS LARRYDirector Sale −2.0M $94.45 $187.3M May 19, 2026 Form 4 ↗
AGUIRRE FERNANDODirector Grant / award +1,563 $97.15 $152K May 14, 2026 Form 4 ↗
Balser Jeffrey R.Director Grant / award +2,058 $97.15 $200K May 14, 2026 Form 4 ↗
KIRBY J SCOTTDirector Grant / award +1,447 $97.15 $141K May 14, 2026 Form 4 ↗
Norwalk Leslie VDirector Grant / award +1,447 $97.15 $141K May 14, 2026 Form 4 ↗
SANSONE GUY PDirector Grant / award +1,447 $97.15 $141K May 14, 2026 Form 4 ↗
BROWN C DAVID IIDirector Grant / award +1,544 $97.15 $150K May 14, 2026 Form 4 ↗
Mandadi TilakEVP, Chief Exp & Tech Officer Sale −69.6K $89.58 $6.2M May 8, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding CVS · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
40.5M$4.19B0.18%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
33.1M$3.42B0.20%Jun 30, 2026
Washington Mutual Investors Fund31.6M$3.30B1.52%Jul 31, 2026
Dodge & Cox Stock Fund
Dodge & Cox Funds
31.7M$3.28B2.77%Jun 30, 2026
Income Fund of America23.7M$2.47B1.67%Jul 31, 2026
American Balanced Fund17.9M$1.85B0.64%Jun 30, 2026
iShares Core S&P 500 ETF
iShares Trust
17.6M$1.82B0.20%Jun 30, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust15.5M$1.60B0.20%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
16.6M$1.56B0.18%Aug 31, 2026
VANGUARD VALUE INDEX FUND
VANGUARD INDEX FUNDS
12.1M$1.26B0.49%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list CVS's shares (CUSIP 126650100), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Dodge & CoxSCHEDULE 13G/A · passive (13G) · 50.0M shares3.9%
    Aug 13, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming cvs health as client
$0$5.0M$10.0M$15.0M$20.0M2023 Q1: $7.5M2023 Q2: $2.0M2023 Q3: $2.0M2023 Q4: $2.2M20232024 Q1: $3.5M2024 Q2: $2.7M2024 Q3: $1.8M2024 Q4: $2.3M20242025 Q1: $3.8M2025 Q2: $2.3M2025 Q3: $2.6M2025 Q4: $2.8M20252026 Q1: $3.8M2026 Q2: $4.1M2026 Q3: $2.6M2026
  • CVS HEALTH (AND SUBSIDIARIES)CVS HEALTH (AND SUBSIDIARIES) · 2026 Q3 · PHA, TAX, MMM, INS$2.0M
    Filing ↗
  • THEGROUP DC, LLCCVS HEALTH (AND SUBSIDIARIES) · 2026 Q3 · HCR, PHA$50K
    Filing ↗
  • MICHAEL BEST STRATEGIES LLCCVS HEALTH · 2026 Q3 · HCR, PHA, MMM, INS$110K
    Filing ↗
  • ALB SOLUTIONSCVS HEALTH (AND SUBSIDIARIES) · 2026 Q3 · HCR$70K
    Filing ↗
  • ALSTON & BIRD LLPCVS HEALTH · 2026 Q3 · HCR$30K
    Filing ↗

Government Contracts

Federal awards to CVS HEALTH Corp · USAspending

No federal contract awards found for CVS HEALTH Corp.

U.S. Patents

Recent USPTO applications naming CVS HEALTH Corp

No USPTO patent applications found for CVS HEALTH Corp.

Annual Financials

From CVS's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$402.07B$372.81B$357.78B$322.47B$292.11B
Operating income$4.66B$8.52B$13.74B$7.95B$13.31B
Net income$1.77B$4.61B$8.34B$4.31B$8.00B
Diluted EPS$1.39$3.66$6.47$3.26$6.02
Operating cash flow$10.64B$9.11B$13.43B$16.18B$18.27B
Cash and equivalents$8.45B$8.59B$8.20B$12.95B$9.41B
Total assets$253.54B$253.22B$249.73B$228.28B$233.00B
Total liabilities$178.16B$177.49B$173.09B$156.51B$157.62B
Shareholders' equity$75.21B$75.56B$76.46B$71.47B$75.08B

As CVS HEALTH Corp tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 10, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitJun 7, 2005
  • 2-for-1Stock splitJun 16, 1998
  • 2-for-1Stock splitMar 15, 1989

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 7.01, 9.01Reg FD disclosureNov 4, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 4, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureAug 17, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.07Officer / director change · Shareholder voteMay 18, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 6, 2026
    EDGAR ↗

About CVS HEALTH Corp

From SEC EDGAR company records
Industry (SIC 5912)Retail-Drug Stores and Proprietary Stores
SectorConsumer
HeadquartersWOONSOCKET, RI
IncorporatedDE
Former namesCVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP